Viewing Study NCT06463834


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-01-09 @ 4:47 AM
Study NCT ID: NCT06463834
Status: RECRUITING
Last Update Posted: 2024-06-18
First Post: 2024-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module